OraSure Story

<div class='circular--portrait' style='background:#82ADFD;color: #ffffff;font-size:3em;'>OSU</div>
OSUR -- USA Stock  

USD 11.24  0.59  5.54%

While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to sum up OraSure. We will evaluate why recent OraSure price moves suggest a bounce in September. Is OraSure current valuation justified? We will cover the entity valuation to give you a better outlook on taking a position in the stock.
Published over a month ago
View all stories for OraSure | View All Stories
The impact of latest bullish trends on OraSure (NASDAQ:OSUR)
The company currently holds 6.91 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the firm is not taking enough advantage from borrowing. On a scale of 0 to 100, OraSure holds a performance score of 3. The company holds a Beta of -0.5857, which implies possible diversification benefits within a given portfolio. Let's try to break down what OraSure's beta means in this case. As returns on the market increase, returns on owning OraSure are expected to decrease at a much lower rate. During the bear market, OraSure is likely to outperform the market. Although it is vital to follow OraSure current trending patterns, it is good to be conservative about what you can do with the information regarding equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing OraSure technical indicators, you can presently evaluate if the expected return of 0.27% will be sustainable into the future. Please employ OraSure jensen alpha, as well as the relationship between the potential upside and accumulation distribution to make a quick decision on whether OraSure historical price patterns will revert.
We determine the current worth of OraSure using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OraSure based exclusively on its fundamental and basic technical indicators. By analyzing OraSure's financials, quarterly and monthly indicators, and related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of OraSure's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of OraSure. We calculate exposure to OraSure's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to OraSure's related companies.

OraSure Investment Alerts

OraSure investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring OraSure performance across your portfolios.Please check all investment alerts for OraSure

OraSure Valuation Ratios as Compared to Competition

Our valuation model uses many indicators to compare OraSure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OraSure competition to find correlations between indicators driving the intrinsic value of OraSure.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for OraSure, but it might be worth checking our own buy vs. sell analysis

Detailed Outlook On OraSure

The latest bullish price patterns experienced by current OraSure shareholders may encourage retail investors to take a closer look at the company as it closed today at a share price of 13.47 on 3,838,509 in trading volume. The company management teams have been very successful in rebalancing the company assets at opportune times to take advantage of market volatility in July. The stock standard deviation of daily returns for 30 days investing horizon is currently 6.13. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the OraSure partners.

Margins Breakdown

OraSure profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or OraSure itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of OraSure profit margins.
Operating Margin5.91
EBITDA Margin0.2
Gross Margin0.69
Profit Margin0.11


OraSure Revenue Per Employee is relatively stable at the moment. Further, OraSure Net Income Per Employee is relatively stable at the moment.

Will OraSure latest spike continue?

The potential upside is down to 7.33 as of today. OraSure is displaying above-average volatility over the selected time horizon. Investors should scrutinize OraSure independently to ensure intended market timing strategies are aligned with expectations about OraSure volatility.

Our Bottom Line On OraSure

While many other companies within the medical instruments & supplies industry are still a little expensive, even after the recent corrections, OraSure may offer a potential longer-term growth to retail investors. The inconsistency in the assessment between current OraSure valuation and our trade advice on OraSure is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to OraSure.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of OraSure. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com